Research Papers
- Investing in a future free of EB – DEBRA RESEARCH IMPACT SUMMARY 2019
- The distribution of epidermolysis bullosa in Australia with a focus on rural and remote areas (2016)
- Patient Information – DEBRA International’s BEST CLINICAL PRACTICE GUIDELINES for skin cancer management in EB (January, 2016)
- Cytoskeletal protein Flightless I inhibits apoptosis, enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progression (2015)
- Pigmented Hair-Thickening Fibers A Camouflage Technique for Alopecia in Patients with Epidermolysis Bullosa
- Botulinum toxin A injection for chronic anal fissures and anal sphincter spasm improves quality of life in recessive dystrophic epidermolysis bullosa (12 August, 2015)
- Clinical study of natural wound healing in Dystrophic Epidermolysis Bullosa (October 23, 2014)
- Understanding the outcomes of a home nursing programme for patients with Epidermolysis Bullosa an Australian perspective (December, 2014)